复方荆防合剂治疗感冒病的临床有效性再评价

发布时间：2018-12-15 07:37

【摘要】：目的:综合中医临床辩证、感染相关临床指标、不良反应关联性等多方面因素观察复方荆防合剂的作用效果与不良反应,为其临床推广与完善提供资料。方法:将2015年1月1日—2015年12月31日符合感冒病纳入标准的患者148例,随机分为治疗组及对照组各74例,治疗组予风热感冒常规治疗+荆防合剂,对照组与予风热感冒常规治疗+银翘片,疗程3日。观察指标包括45白细胞、单核细胞、体温疗效、中医证候积分、中医证候疗效、疾病疗效与安全性评价。结果:治疗组发热、咽痛、流涕、总分较对照组有统计学差异(P0.05),治疗组白细胞、单核细胞、体温疗效、中医证候疗效、疾病疗效与安全性评价与对照组无统计学差异(P0.05)。结论:复方荆防合剂疗效显著,能有效改善症状、证候,降低感染性指标,毒副作用小,值得临床推广应用。
[Abstract]:Objective: to observe the effect and adverse reaction of compound Jingfang mixture by synthesizing the clinical dialectics of traditional Chinese medicine, infection related clinical index, adverse reaction correlation and so on, so as to provide data for its clinical popularization and perfection. Methods: 148 patients who met the standard of colds from January 1, 2015 to December 31, 2015 were randomly divided into treatment group (n = 74) and control group (n = 74). The control group was treated with Yinqiao tablet for 3 days. The observed indexes include 45 leukocytes, monocytes, body temperature, TCM syndromes, disease efficacy and safety evaluation. Results: the total score of fever, pharynx pain, runny discharge in the treatment group was significantly higher than that in the control group (P0.05). The effect of leukocyte, monocyte, body temperature, TCM syndromes, and syndromes in the treatment group were significantly different from those in the control group. There was no statistical difference between the disease efficacy and safety evaluation and the control group (P0.05). Conclusion: compound Jingfang mixture is effective in improving symptoms, syndromes, reducing infectious indexes, and has less toxic and side effects, which is worth popularizing in clinic.
【作者单位】：上海中医药大学附属岳阳中西医结合医院急诊医学科;
【基金】：上海市进一步加快中医药事业发展三年行动计划(2014-2016年)建设项目(ZY3-JSFC-2-1042)
【分类号】：R254.9

【相似文献】